nally described by our group for the treatment of Camurati-Engelmann disease 18 and subsequently modified for the treatment of slit-ventricle syndrome, 10 ICE involves removal of the skull's inner calvarial table and cancellous bone to effect an increase in the volume of the intracranial compartment (Fig. 1) . This increased intracranial volume enables expansion of the intracranial contents (brain, blood, and CSF) and thus decreases ICP. Here, we describe our initial experience with ICE for the definitive surgical treatment of patients with refractory IIH. The surgical technique is presented with delineation of complications and clinical outcomes. We also discuss how our results may shed light on the etiology of this heretofore poorly understood condition.
Methods

Patient Population
Between 2007 and 2011, ICE was performed in 10 consecutive patients diagnosed with IIH that was refractory to medical treatment and, in some cases, other surgical treatment. The clinic chart, electronic medical records, and available radiographic studies for each patient were retrospectively reviewed. Baseline clinical characteristics, prior surgical interventions, perioperative details, available pre-and postoperative ICP measurements, and clinical assessment at the last follow-up clinic visit were noted.
Image Analysis
Preoperative and postoperative noncontrast head CT scans were obtained for volumetric analysis in 4 patients. Similar to methodology previously described, 2, 10, 25 we used the public domain image processing program ImageJ 1.44p (National Institutes of Health) to calculate intracranial volume change. Briefly, CT image stacks composed of raw DICOM (Digital Imaging and Communication in Medicine) files were opened within ImageJ. Scale and slice thickness were set for each stack based on metadata contained within each DICOM file. Using bone windows, automated selection and calculation of the intracranial compartment area were performed for each slice. All intracranial compartment area selections were visually confirmed to be bound by the inner table of the skull. An intracranial compartment slice volume was calculated by multiplying the intracranial compartment area (A) by the slice thickness (T) as follows: (V slice = A slice × T slice ). The total intracranial compartment volume (V) was calculated by summing individual intracranial compartment slice volumes from the skull vertex to the foramen magnum (V total = S V slice ).
Surgical Procedure
Although it has been previously described, 10,18 the ICE procedure is elaborated here for the benefit of the reader. The patient is positioned supine with the head neutral or slightly flexed on a horseshoe headrest. Alternatively, rigid cranial stabilization using 3-point fixation may be used. The scalp is prepared in a usual sterile fashion, and craniotomy drapes are placed. An extended zigzag coronal incision encompassing the retroauricular regions bilaterally is then fashioned. The temporalis fascia is left intact, and the muscle is not taken down. The scalp is then reflected anteriorly and posteriorly, providing wide exposure of the cranium. Using a surgical marking pen, large bilateral craniotomies are outlined and numbered anterior and posterior to the coronal suture (Fig.  2 ). Bony struts (1.5-2 cm wide) are maintained along the coronal suture and orthogonally over the sagittal sinus. The 4 outlined craniotomies are turned, and the flaps are taken to a sterile side table where another surgeon works to remove the inner cortical and cancellous layers using a drill, osteotome, and oscillating saw as needed. The inner table and cancellous layer of the struts and of the remaining frontal, temporal, and parietal bones are drilled off as low as possible to the skull base. Entrance into the frontal sinus is avoided. Care is also taken to protect the underlying dura with a malleable brain retractor during drilling. The thinned bone flaps from the side table are then replaced using titanium plates and screws, thus preserving the integrity and rigidity of the skull while expanding the intracranial volume (Fig. 3) . A Jackson-Pratt drain is placed in the subgaleal space, and the scalp is closed in the usual fashion.
Results
Clinical Characteristics
The study cohort includes 3 male and 7 female patients who ranged in age from 11 to 61 years at the time of ICE surgery ( Table 1 ). All but 1 patient (Case 4) presented with intractable headaches, and most patients (7 of 10) also had visual symptoms including blurry vision, transient visual obscurations, or vision loss over a period ranging from 2 months to 31 years prior to ICE. Elevated lumbar CSF opening pressures, typically greater than 30 cm H 2 O, were noted in all patients. Papilledema was observed in 4 patients preoperatively. All female patients were noted to be either overweight with a BMI of 25-29 (1 of 7 patients) or obese with a BMI of 30 or more (6 of 7 patients). The 3 male patients each had a normal BMI.
Prior to surgical referral, all patients were initially treated medically with 1 or more carbonic anhydrase inhibitors (acetazolamide or topiramate), a loop diuretic (furosemide), and/or corticosteroids. Additionally, pain management was initiated by a multidisciplinary team, and weight loss was encouraged for overweight or obese patients. In 5 patients (Cases 1-3, 5, and 10), surgical therapies including LP, VP, and/or lumbopleural shunt treatment, and/or ONSF were previously performed for medically refractory IIH (Table 1) . In these cases, often after multiple revision surgeries, the signs and symptoms of intracranial hypertension persisted prior to ICE.
Perioperative Details and Surgical Complications
Select perioperative details have been summarized in Table 2 . Technically successful internal cranial expansion was achieved in all patients within the cohort. All previously placed shunt hardware (valves, proximal, and distal catheters) was removed without replacement at the time of ICE. The ICE procedure duration varied between 3 and 6.2 hours (mean 4.6 hours), and intraoperative blood loss ranged from 200 to 1000 ml (mean 456 ml). Procedure-related complications were encountered in 2 patients. In one of these patients (Case 3) a single, self-limited episode of secondarily generalized tonicclonic seizure occurred on postoperative Day 8. Small, localized hyperintense T2/FLAIR signals were noted on postoperative MRI in the right frontal and parietal lobes. No MRI evidence of stroke or electroencephalographic seizure activity during continuous electroencephalography monitoring was seen. In the other patient (Case 9), a tear in the sagittal sinus resulted in blood loss requiring intraoperative transfusion of 1 U of packed red blood cells. The dural defect was repaired with an autologous pericranial patch, and no clinical sequelae were observed.
Clinical Outcomes
Follow-up for the 10 patients in this series ranged from 1 to 39.6 months (mean 15.5 months). In total, 7 (70%) of the 10 patients were either symptomatically improved or asymptomatic at the time of the last followup visit. The remaining patients included 2 (Cases 3 and 8) who had only temporary postoperative symptomatic improvement and 1 (Case 1) who had no postoperative improvement. Importantly, these 3 patients had documentation of normal ICP or lumbar CSF opening pressure postoperatively, indicating that adequate decompression was accomplished. Headaches were completely resolved or reduced in intensity and frequency in 6 of 9 patients with this symptom at presentation. Similarly, a reduction or complete resolution of papilledema was noted in all patients (4 of 4) with this sign at presentation. Improvement or stabilization of other symptoms including visual complaints, tinnitus, retroorbital pain, and ear pain were also noted for some patients within the cohort (Table 3) .
Intracranial Volume Measurements
Similar to previously reported values in patients un- dergoing ICE for slit-ventricle syndrome, 10 volumetric analysis shows postoperative intracranial volume expansion ranging between 3.8% and 12% in this series. The expanded epidural compartment created during the ICE procedure was seen to be nearly completely obliterated in all patients who underwent postoperative head CT scanning. This nearly complete obliteration was seen as early as 2 weeks after ICE and occurred due to progressive dural relaxation, with circumferential expansion of the intradural contents until they became apposed to the skull. Computed tomography evidence of brain relaxation with increased sulcation was also observed (Fig. 4) .
Discussion
Walter Dandy was the first neurosurgeon to routinely use cranial decompression surgery in the treatment of patients with IIH. In his landmark series of 22 cases published in 1937, Dandy explained, "This condition is both immediately and permanently controlled (possibly with rare exceptions) by a subtemporal decompression." 6 However, this procedure has been largely abandoned due to the development of first-line pharmacological therapies and because more contemporary subtemporal decompression series have indicated that many patients will eventually require CSF diversion. 13 Our experience and success with using ICE to treat the rare disorder Camurati-Engelmann disease and the more common slit-ventricle syndrome suggested that the same surgical principles may be applied in the treatment of patients with refractory IIH.
In this series, we show that ICE enabled improvement or complete resolution of symptoms in the majority (7 of 10) of patients undergoing the procedure. At least temporary symptomatic improvement was observed in all but 1 patient. Importantly, most patients (6 of 9) had improvement or complete resolution of intractable headaches, and all patients had improvement or complete resolution of papilledema (4 of 4) after undergoing ICE. Postoperative normalization of ICP was directly demonstrated in 2 patients by extended parenchymal (Case 1) or intraventricular (Case 8) pressure monitoring, while a significant reduction in lumbar CSF opening pressure was observed in 2 additional patients (Cases 3 and 5). Of note, the 3 patients (Cases 1, 3, and 8) who did not have postoperative reduction or resolution of symptoms also did not have evidence of continued intracranial hypertension measured by ICP monitoring or CSF opening pressure (Table 3) . For these patients, management of symptoms is challenging and must be undertaken by a multidisciplinary team consisting of neurologists, pain specialists, mental health practitioners, and social workers.
While all current surgical therapies for IIH have been used effectively in select patients, 4, 30 we believe that ICE offers several distinct advantages in a broader cohort of patients. Optic nerve sheath fenestration has been shown safe and effective for preventing deterioration of vision in patients with IIH; 1, 4 however, postoperative complication rates as high as 40% per eye have been reported. 21 These complications may include temporary motility or pupillary dysfunction, as well as vascular complications such as central retinal artery occlusion, resulting in poor visual outcome. Optic nerve sheath fenestration is also not effective for reducing ICP or for relieving headache and has a reported failure rate of 35% by 3-5 years. 4, 7, 26 On the other hand, shunting (LP, VP, and ventriculopleural) procedures more effectively address increased ICP and headaches but are similarly plagued by high failure rates, necessitating repeat surgery. In a review by Rosenberg et al. 24 of CSF diversion procedures in patients with IIH, it was shown that 64% of shunts lasted for shorter than 6 months. Ventriculoperitoneal shunting can create shunt dependence, 15 cause overdrainage symptoms, 16, 31 and subject the patient to infection due to permanent hardware implantation. The completely extradural surgical approach of ICE enables avoidance of the hemorrhagic and cortical scarring complications associated with intraventricular catheter placement. Challenging placement and maintenance of patency of the intraventricular catheter inside slit-like ventricles is also avoided. Nonetheless, 1 patient in our series had a perioperative seizure, and another patient sustained a sagittal sinus tear; both complications underscore the general risks of any extra- dural surgery and the specific risk of working around the midline.
The etiology of IIH is not understood and for this reason IIH has been termed a "disease of theories." 7 However, decreased CSF absorption due to increased venous pressure is a widely cited pathogenic mechanism. 4, 7, 11, 12, 27 It is possible that by increasing the space for the sagittal sinus and other cortical veins, ICE reduces intracranial venous pressure, restoring a more physiological pressure gradient across the arachnoid granulations and promoting CSF absorption. This hypothesis could be addressed in future studies in which sinus pressures are either directly measured during catheter angiography or calculated with the use of noninvasive quantitative MR angiography technology such as NOVA (VasSol, Inc.). 5, 14, 22 Another intriguing yet untested hypothesis for the etiology of IIH is that it results from having a congenitally small cranial vault. It is conceivable that patients with relatively small intracranial volumes may have an increased likelihood of intracranial hypertension. Indeed, our observation of continued sulcal effacement in a patient with IIH despite the presence of a functional VP shunt suggested that a relatively small supratentorial compartment might have contributed to his symptoms (Fig. 4) . Thus, analogous to the "small posterior fossa" theory of Chiari malformation Type I, 3, 17, 19, 20 ,28,29 we propose the "small supratentorial compartment" theory of IIH. For patients with IIH, ICE decompresses the supratentorial space much in the way that a suboccipital craniectomy decompresses the posterior fossa in patients with Chiari malformation Type I.
Conclusions
Internal cranial expansion is a safe and effective surgery for the treatment of patients with refractory IIH. This procedure results in increased intracranial volume enabling ICP normalization, which obviates the need for CSF diversion in this population. Improvement or complete resolution of headaches, visual complaints, papilledema, and other signs and symptoms related to intracranial hypertension may be seen in patients who undergo ICE. A multidisciplinary approach should be used for the optimal management of patients with IIH and is especially important in patients who remain symptomatic despite the ICP normalization conferred by ICE. Additional clinical and basic research is needed to clarify the pathogenesis of this vexing disorder.
